US MedTech leader Karen Holzberger appointed CEO
Filed with ASX · · 3 pages · English
Earlier from PainChek
- CEO Transition
- PainChek secures A$5.5m note to fund US expansion
- Landmark Sabra North America deployment targeting 20k beds
- PainChek reports material sales momentum in UK
- Half Yearly Report and Accounts
Later from PainChek
- PainChek receives $1.123 million R&D tax incentive refund
- Quarterly Activities/Appendix 4C Cash Flow Report
- Change of Director's Interest Notice x 4
- Update - Notification regarding unquoted securities - PCK
- PainChek Investor Webinar
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek